5269 completed. 5269 Phase 1, 84 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5269 | Completed 5269 |
| Phase 2 | 84 | Completed 84 |
Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight BI 3034701 (C-14) - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 8 | 2026-08-24 | 2026-11-05 |
| A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007) MK-1403 formulation (FM) 1 + additive, MK-1403 FM2 + additive - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 15 | 2026-08-14 | 2026-10-09 |
| A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole Sifrol®, Mirapex® - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 25 | 2026-08-05 | 2026-09-29 |
| Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants AZD4144, Itraconazole - Healthy | Phase 1 | Completed | AstraZeneca | 32 | 2026-07-30 | 2026-11-03 |
| A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005) MK-4082, Diltiazem, Rescue medication - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 28 | 2026-07-20 | 2026-11-02 |
| A Study in Healthy Men to Test How BI 1815368 is Processed in the Body BI 1815368 (C-14), BI 1815368 (C-13) - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 8 | 2026-07-16 | 2026-09-15 |
| A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants BL1332 eye drops, BL1332 Placebo eye drops - Healthy | Phase 1 | Completed | Bausch & Lomb Incorporated | 28 | 2026-07-06 | 2026-09-10 |
| A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants Tersolisib, High-fat Meal, Low-fat Meal - Healthy | Phase 1 | Completed | Eli Lilly and Company | 60 | 2026-07-01 | 2026-10-14 |
| A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003) MK-7262, Enlicitide - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 30 | 2026-07-01 | 2026-09-25 |
| A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the Blood Zongertinib, Bosentan - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 16 | 2026-06-22 | 2026-09-04 |
| The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg - Healthy, Fasting | Phase 1 | Completed | LG Chem | 28 | 2026-06-11 | 2026-09-10 |
| A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants Verducatib - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 12 | 2026-06-10 | 2026-09-21 |
| A Study of LY4065967 in Healthy Participants LY4065967 Tablet, LY4065967 Formulated Capsule, LY4065967 Capsule - Healthy | Phase 1 | Completed | Eli Lilly and Company | 36 | 2026-06-03 | 2026-08-19 |
| A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020) MK-8527, Methadone - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 14 | 2026-05-22 | 2026-08-26 |
| A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants LY4395089, Itraconazole - Healthy | Phase 1 | Completed | Eli Lilly and Company | 14 | 2026-05-20 | 2026-08-25 |
| A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults PF-08049820, Rabeprazole - Healthy Adults, Healthy | Phase 1 | Completed | Pfizer | 24 | 2026-05-13 | 2026-10-01 |
| A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646) Bictegravir/emtricitabine/tenofovir alafenamide, Dolutegravir, MK4646 - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 16 | 2026-05-11 | 2026-08-25 |
| A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017) Opevesostat, Prednisone, Fludrocortisone acetate - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 14 | 2026-05-11 | 2026-06-25 |
| A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults. PF-08057418, Placebo (A placebo does not have any medicine in it but looks just like the medicine being studied.) - Healthy | Phase 1 | Completed | Pfizer | 8 | 2026-05-08 | 2026-07-24 |
| A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018) Atorvastatin, Metformin, Ulonivirine - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 12 | 2026-04-29 | 2026-06-15 |
Showing 20 of 5269. Sign in to see all of them.
Diabetes Mellitus (104) · Diabetes Mellitus, Type 2 (40) · Renal Insufficiency (31) · Obesity (28) · Alzheimer Disease (24) · Overweight (15) · Fasting (14) · Inflammation (14) · Influenza, Human (13) · Respiratory Aspiration (11) · Acquired Immunodeficiency Syndrome (10) · Arthritis, Rheumatoid (10) · COVID-19 (10) · Hepatic Insufficiency (10) · Lecithin Cholesterol Acyltransferase Deficiency (10)
Nutritional and Metabolic Diseases (192) · Metabolic Diseases (159) · Endocrine System Diseases (131) · Glucose Metabolism Disorders (129) · Pathological Conditions, Signs and Symptoms (128) · Infections (85) · Signs and Symptoms (70) · Nervous System Diseases (68) · Respiratory Tract Diseases (66) · Urogenital Diseases (64) · Virus Diseases (63) · Mental Disorders (61) · RNA Virus Infections (59) · Pathologic Processes (56) · Immune System Diseases (53)
Metformin (115) · Moxifloxacin (96) · Midazolam (91) · Itraconazole (82) · Tablets (75) · Rosuvastatin Calcium (63) · Omeprazole (57) · Ritonavir (48) · Dabigatran (42) · Linagliptin (42) · Digoxin (41) · Rifampin (40) · empagliflozin (38) · Canagliflozin (36) · Warfarin (33)
Boehringer Ingelheim (742) · Pfizer (321) · Eli Lilly and Company (256) · Janssen Research & Development, LLC (199) · Teva Pharmaceuticals USA (161) · Dr. Reddy's Laboratories Limited (156) · Mylan Pharmaceuticals Inc (145) · AstraZeneca (126) · Novo Nordisk A/S (121) · Merck Sharp & Dohme LLC (97) · Actavis Inc. (65) · Lakefront Biotherapeutics NV (61) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (54) · Torrent Pharmaceuticals Limited (52) · Wyeth is now a wholly owned subsidiary of Pfizer (50)
United States (1840) · Germany (437) · South Korea (329) · Belgium (326) · United Kingdom (299) · China (212) · Canada (209) · Japan (161) · India (144) · Netherlands (132) · Australia (89) · Singapore (77) · Switzerland (50) · France (43) · Sweden (42)
James D Carlson, Pharm. D. (50) · Dorian Williams, M.D. (41) · Ahmed Elshafeey, Ph.D. Pharma (34)
PMID 33128208, PMID 25078976, PMID 36451029, PMID 20844485, PMID 24868146, PMID 25078977, PMID 29856004, PMID 32348036, PMID 33969456, PMID 34473343, PMID 35061234, PMID 40455255, PMID 23497760, PMID 24408516, PMID 25345427, PMID 27140803, PMID 30908082, PMID 33654425, PMID 35344588, PMID 36919398, PMID 37917289, PMID 38054726, PMID 38267790, PMID 39175217, PMID 40117091, PMID 42563128, PMID 10454950, PMID 1490793, PMID 18832427, PMID 20126394, PMID 21480191, PMID 23811290, PMID 23926058, PMID 24491572, PMID 25350224, PMID 25659911, PMID 25681059, PMID 26381275, PMID 27136908, PMID 28230262, PMID 28349387, PMID 29363027, PMID 29500603, PMID 29749279, PMID 29912955, PMID 30098648, PMID 30412360, PMID 30497798, PMID 30565096, PMID 31012984
2014 (68), 2015 (68), 2018 (58), 2017 (55), 2019 (53), 2016 (45), 2023 (39), 2009 (29), 2025 (16), 2008 (14), 2005 (7), 2004 (3), R01GM036780 (2), U19AI057229 (2), 272201600009C-2-0-1 (1)